Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03117582 · ClinicalTrials.gov registry record
Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 34
- Enrollment target
NCT03117582: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT03117582 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03117582 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
Purpose: To study the changes in the microbiome and stool composition in patients with Clostridium Difficile Infection (CDI) who undergo Fecal Microbiota Transplantation (FMT), along with changes in their clinical characteristics.
Primary Outcome
Diarrhea is defined as three or more unformed stools for more than two consecutive days.
Interventions
- OTHER Stool specimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-12 |
| Est. Completion | 2020-12-11 |
What the finished NCT03117582 record still lists
NCT03117582 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Stool specimen is the first listed.
NCT03117582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03117582 about?
NCT03117582 is a clinical study titled "Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics". Purpose: To study the changes in the microbiome and stool composition in patients with Clostridium Difficile Infection (CDI) who undergo Fecal Microbiota Transplantation (FMT), along with changes in their clinical characteristics.
What is the current status of trial NCT03117582?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2016-12. Estimated completion is 2020-12-11.
What interventions are being tested in trial NCT03117582?
The interventions under investigation include: Stool specimen (OTHER).
Who is sponsoring clinical trial NCT03117582?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia